BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 15117816)

  • 1. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair.
    Mayr U; Zou Y; Zhang Z; Dietrich H; Hu Y; Xu Q
    Circ Res; 2006 Feb; 98(3):412-20. PubMed ID: 16385078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice.
    Xu Q; Zhang Z; Davison F; Hu Y
    Circ Res; 2003 Oct; 93(8):e76-86. PubMed ID: 14512446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
    Gessaroli M; Bombardi C; Giunti M; Bacci ML
    J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
    Poston RS; Gu J; Brown JM; Gammie JS; White C; Nie L; Pierson RN; Griffith BP
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):122-30. PubMed ID: 16399303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
    Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
    J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
    Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts.
    Schachner T; Zou Y; Oberhuber A; Mairinger T; Tzankov A; Laufer G; Ott H; Bonatti J
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):585-90. PubMed ID: 15037276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts.
    Schachner T; Oberhuber A; Zou Y; Tzankov A; Ott H; Laufer G; Bonatti J
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):302-6. PubMed ID: 15691686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
    Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
    Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
    Walpoth BH; Zammaretti P; Cikirikcioglu M; Khabiri E; Djebaili MK; Pache JC; Tille JC; Aggoun Y; Morel D; Kalangos A; Hubbell JA; Zisch AH
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1163-70. PubMed ID: 17467424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine model of neointimal formation and stenosis in vein grafts.
    Cooley BC
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1180-5. PubMed ID: 15105282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
    Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
    Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation.
    Sakaguchi T; Asai T; Belov D; Okada M; Pinsky DJ; Schmidt AM; Naka Y
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):129-37. PubMed ID: 15632834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
    Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
    Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.